Pharmacokinetics and pharmacodynamics of azelnidipine in experimental animals and patients with essential hypertension

被引：0
|
作者：
Matsushima, Nobuko [1 ]
Naganuma, Hideo [1 ]
Saito, Hironobu [1 ]
Sada, Toshio [1 ]
Ikeda, Toshihiko [1 ]
Koike, Hiroyuki [1 ]
机构：
[1] Sankyo Co Ltd, Res Dev Headquarters, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [31] ALTERED PHARMACOKINETICS AND PHARMACODYNAMICS OF ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART-FAILURE VERSUS PATIENTS WITH HYPERTENSION
    SCHWARTZ, JB
    TAYLOR, AA
    ABERNETHY, DR
    OMEARA, ME
    FARMER, JA
    YOUNG, JB
    NELSON, EB
    POOL, JL
    MITCHELL, JR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 544 - 544
  • [32] INTRAVENOUS NIFEDIPINE FOR POST CABG HYPERTENSION - PHARMACOKINETICS AND PHARMACODYNAMICS
    NATHAN, H
    LALANDE, M
    DUBE, L
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : B71 - B71
  • [33] PHARMACOKINETICS AND PHARMACODYNAMICS OF NAPROXEN IN ACUTE EXPERIMENTAL HEPATITIS
    FAVARI, L
    CASTANEDAHERNANDEZ, G
    HOYOVADILLO, C
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (06): : 675 - 679
  • [34] Experimental Investigation of Pharmacodynamics and Pharmacokinetics of Carbamazepine Nanoemulsion
    Prokhorov, D. I.
    Sariev, A. K.
    Abramov, D. A.
    Voronina, T. A.
    Kapitsa, I. G.
    Zhuravko, A. S.
    Shiriaeva, M. V.
    Kaplun, A. P.
    Seifulla, R. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (06) : 742 - 746
  • [35] Experimental Investigation of Pharmacodynamics and Pharmacokinetics of Carbamazepine Nanoemulsion
    D. I. Prokhorov
    A. K. Sariev
    D. A. Abramov
    T. A. Voronina
    I. G. Kapitsa
    A. S. Zhuravko
    M. V. Shiriaeva
    A. P. Kaplun
    R. D. Seifulla
    Bulletin of Experimental Biology and Medicine, 2014, 157 : 742 - 746
  • [36] Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension -: a population analysis
    Meineke, I
    Feltkamp, H
    Högemann, A
    Gundert-Remy, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (3-4) : 221 - 228
  • [37] Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension – a population analysis
    I. Meineke
    H. Feltkamp
    A. Högemann
    U. Gundert-Remy
    European Journal of Clinical Pharmacology, 1997, 53 : 221 - 228
  • [38] Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients
    Donald L. Yee
    Sarah H. O’Brien
    Guy Young
    Clinical Pharmacokinetics, 2013, 52 : 967 - 980
  • [39] PHARMACOKINETICS AND PHARMACODYNAMICS OF VECURONIUM IN PATIENTS WITH CHOLESTASIS
    LEBRAULT, C
    DUVALDESTIN, P
    HENZEL, D
    CHAUVIN, M
    GUESNON, P
    BRITISH JOURNAL OF ANAESTHESIA, 1986, 58 (09) : 983 - 987
  • [40] Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients
    Yee, Donald L.
    O'Brien, Sarah H.
    Young, Guy
    CLINICAL PHARMACOKINETICS, 2013, 52 (11) : 967 - 980
12345